Journal of Pediatric Neurology 2009; 07(04): 401-404
DOI: 10.3233/JPN-2009-0321
Case Report
Georg Thieme Verlag KG Stuttgart – New York

Urinary retention in acute lymphoblastic leukemia induction therapy: Two distinct pathologies

Ali Bay
a   Department of Pediatrics, Dr. Sami Ulus Children's Hospital, Ankara, Turkiye
,
Pamir Isik
a   Department of Pediatrics, Dr. Sami Ulus Children's Hospital, Ankara, Turkiye
,
Nese Yarali
a   Department of Pediatrics, Dr. Sami Ulus Children's Hospital, Ankara, Turkiye
,
Serdar Ozkasap
a   Department of Pediatrics, Dr. Sami Ulus Children's Hospital, Ankara, Turkiye
,
Abdurrahman Kara
a   Department of Pediatrics, Dr. Sami Ulus Children's Hospital, Ankara, Turkiye
,
Bahattin Tunc
a   Department of Pediatrics, Dr. Sami Ulus Children's Hospital, Ankara, Turkiye
› Author Affiliations

Subject Editor:
Further Information

Publication History

09 October 2009

09 October 2009

Publication Date:
30 July 2015 (online)

Abstract

Intrathecal chemotherapy and systemic chemotherapy are used for both prophylaxis and treatment of central nervous system disease in hematologic malignancies. We presented two children with urinary retention due to neurotoxicity with two distinct drugs and reasons. The main presenting complaints were urinary retention and incontinence in both patients. Before the adverse clinical event, the patients had received vincristine intravenously and triple therapy with hydrocortisone, cytosine arabinoside, and methotrexate intrathecally. The clinical event resolved, and vincristine and intrathecal chemotherapy were deleted from the patients subsequent therapy until recovery was achieved.